Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Hilfiker-Kleiner, Denise  [Clear All Filters]
Journal Article
Schoenherr C, Wohlan K, Dallmann I, Pich A, Hegermann J, Ganser A, Hilfiker-Kleiner D, Heidenreich O, Scherr M, Eder M. Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase. PLoS One. 2019;14(12):e0225977.
Lee C-W, Schoenherr C, Battmer K, Ganser A, Hilfiker-Kleiner D, David S, Eder M, Scherr M. miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo. PLoS One. 2018;13(10):e0204942.
Stelling E, Ricke-Hoch M, Erschow S, Hoffmann S, Bergmann AKatharina, Heimerl M, Pietzsch S, Battmer K, Haase A, Stapel B, et al. Increased prostaglandin-D2 in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation. PLoS Biol. 2020;18(12):e3000739.
Lux M, Andrée B, Horvath T, Nosko A, Manikowski D, Hilfiker-Kleiner D, Haverich A, Hilfiker A. In vitro maturation of large-scale cardiac patches based on a perfusable starter matrix by cyclic mechanical stimulation. Acta Biomater. 2015.
Ricke-Hoch M, Hoes MF, Pfeffer TJ, Schlothauer S, Nonhoff J, Haidari S, Bomer N, Scherr M, Stapel B, Stelling E, et al. In peripartum cardiomyopathy Plasminogen Activator Inhibitor-1 is a potential new biomarker with controversial roles. Cardiovasc Res. 2019.
Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch AP, Kasten M, Zapatero-Belinchón FJ, Brogden G, Gerold G, Pietschmann T, Montiel V, et al. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021;16(8):e0255335.
Zheng X, Halle S, Yu K, Mishra P, Scherr M, Pietzsch S, Willenzon S, Janssen A, Boelter J, Hilfiker-Kleiner D, et al. Cardiomyocytes display low mitochondrial priming and are highly resistant towards cytotoxic T-cell killing. Eur J Immunol. 2016.